CERE Code AS

11553038

Company info

CERE Code AS

11553038

Genecode - Developing novel 
disease modifying drugshttps://molcode.comGenecode - Developing novel 
disease modifying drugs

Our mission is a simple question we ask ourselves — can we slow down or stop neurodegeneration when treating chronic neurological diseases?

General info

Name

CERE Code AS

Registry code

11553038

Type

AS - Joint Stock Company

Status

Registered

Foundation date

14.11.2008 (16)

Financial year

01.01-31.12

Capital

25 600.00 €

Activity

72111 - Research and experimental development on biotechnology

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

MS Code OÜ

12043010

20% - 5 120.00 EUR - - Shareholder

Omanikukonto: TÕNIS TIMMUSK

07.01.1959 (65)

10% - 2 560.00 EUR - Direct ownership Shareholder

Mehis Pilv

13.01.1947 (77)

10% - 2 560.00 EUR - Direct ownership Board memberShareholder

AnsonBaer VOCP OÜ

14847450

40% - 10 240.00 EUR - - Shareholder

Loore Nuut

19.05.1965 (59)

- Board member -

Mart Saarma

29.06.1949 (75)

- - Direct ownership

Mati Karelson

27.12.1948 (75)

- - Direct ownership

Thomas Björn Waldin

01.08.1942 (82)

- - Direct ownership

Marliis Rosenbaum

17.11.1982 (42)

- - - Board member

Paavo Pilv

12.02.1976 (48)

- - - Board member

GeneCode AS

10362550

- - - Founder